Editorial · 2022 · Open access

Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials

Noah Goodson, Paul J Wicks, C. Farina

Trials, 23(1), 966 · Published 28 November 2022 · DOI 10.1186/s13063-022-06905-6

Open PDFView at the publisherCite this paper

In brief

“Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials” is an 2022 editorial by Noah Goodson and 2 co-authors, published in Trials. OpenAlex counts 4 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Trials.

Citations
4
Most cited in
2024 (2)
References
14
Authors
3

Abstract

It is increasingly recognized that involving patients and the public in the design of clinical trials can lead to better recruitment, retention, and satisfaction. A recent scoping review determined that between 1985 and 2018, just 23 articles meeting quality criteria obtained feedback from clinical trial participants after a trial had been completed. In a timespan that presumably included thousands of trials across hundreds of indications, the paucity of the literature seems surprising, if not outright disappointing. By contrast, practitioners in the life sciences industry are increasingly incorporating patient research into their trial design process before, during, and after trial completion. Examples of approaches used include recruitment of "look alike" participant samples through online communities, surveys, and the use of smartphone apps to directly record participants' spoken reactions to trial materials like recruitment materials, site visit schedules, or informed consent materials. However, commercial organizations tend not to publish their findings, leading to a potential two-tier experience for trial participants depending on whether the trial they participate in will be industry-funded or government-funded. This seems problematic on a number of levels. Increasing regulatory, funder, and publisher interest in improving the inclusivity of clinical trial participants may act as a timely lever to spur patient-centered coproduction of trials. Until continuous feedback processes are the mandated, funded, and published norm, participating in a clinical trial will be more arduous than it needs to be.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Goodson, N., Wicks, P. J., & Farina, C. (2022). Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials. Trials, 23(1), 966. https://doi.org/10.1186/s13063-022-06905-6

MLA 9

Goodson, Noah, et al. “Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials.” Trials, vol. 23, no. 1, 2022, p. 966. https://doi.org/10.1186/s13063-022-06905-6.

Chicago

Goodson, Noah, Paul J Wicks, and C. Farina. 2022. “Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials.” Trials 23 (1): 966. https://doi.org/10.1186/s13063-022-06905-6.

Harvard

Goodson, N., Wicks, P. J. and Farina, C. (2022) ‘Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials’, Trials, 23(1), p. 966. doi:10.1186/s13063-022-06905-6.

IEEE

N. Goodson, P. J. Wicks, and C. Farina, “Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials,” Trials, vol. 23, no. 1, p. 966, 2022, doi: 10.1186/s13063-022-06905-6.

BibTeX

@article{goodson2022commentary,
  title     = {{Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials}},
  author    = {Goodson, Noah and Wicks, Paul J and Farina, C.},
  journal   = {Trials},
  year      = {2022},
  volume    = {23},
  number    = {1},
  pages     = {966},
  doi       = {10.1186/s13063-022-06905-6},
  url       = {https://doi.org/10.1186/s13063-022-06905-6}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202422
202511
202611

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • patient and public involvement
  • clinical trial design
  • participant feedback
  • participant recruitment and retention
  • industry-sponsored trials
  • online communities
  • mobile application
  • informed consent

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Goodson, N., Wicks, P. J., & Farina, C. (2022). Commentary: an industry perspective on the importance of incorporating participant voice before, during, and after clinical trials. Trials, 23(1), 966. https://doi.org/10.1186/s13063-022-06905-6

How many times has this paper been cited?

4 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Trials: sign in and open the PDF from this page.

Who wrote this paper?

Noah Goodson, Paul J Wicks, C. Farina.

What is the DOI of this paper?

10.1186/s13063-022-06905-6, permanently at https://doi.org/10.1186/s13063-022-06905-6. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.